Clinical Trial Update: Assessment of Blood Biomarkers by DNA Microarrays in Patients With Aggressive Lymphoma BMS_LyTrans

View source ↗

Summary

This completed study investigates blood biomarkers in patients with diffuse large B-cell lymphoma using DNA microarray analysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Rennes University Hospital | Conditions: DLBCL | Status: COMPLETED